subscribeSubscribe
Taiwan pulls weight-loss drug from market over cancer concerns

Taiwan pulls weight-loss drug from market over cancer concerns
Ching-Tse Cheng TWAIWANNNEWS
16 Jul 2020
Share Share
Eisai will pull Belviq off U.S. shelves on cancer concerns

Eisai will pull Belviq off U.S. shelves on cancer concerns
Kyle Blankenship FIERCE PHARMA
14 Feb 2020
Share Share
Belviq, Belviq XR by Eisai - FDA Requests Withdrawal of Weight-Loss Drug

Belviq, Belviq XR by Eisai - FDA Requests Withdrawal of Weight-Loss Drug
FDA
14 Feb 2020
Share Share
FDA Warns of Potential Cancer Risk With Weight Loss Drug

FDA Warns of Potential Cancer Risk With Weight Loss Drug
Zachary Brennan RAPS
14 Jan 2020
Share Share
Zydus Receives USFDA Tentative Approval For Lorcaserin Hydrochloride Tablet

Zydus Receives USFDA Tentative Approval For Lorcaserin Hydrochloride Tablet
PHARMABIZ
03 Dec 2019
Share Share
Zydus Pharmaceutical`s Generic Lorcaserin Hydrochloride Receives Approval in US

Zydus Pharmaceutical`s Generic Lorcaserin Hydrochloride Receives Approval in US
FDA
02 Dec 2019
Share Share
United Therapeutics pays $800M-plus to grab Arena’s PhIII PAH drug

United Therapeutics pays $800M-plus to grab Arena’s PhIII PAH drug
ENDPTS
16 Nov 2018
Share Share
Eisai signs pact with Eurofarma for anti-obesity agent

Eisai signs pact with Eurofarma for anti-obesity agent
BIOSPECTRUM
16 Oct 2018
Share Share
Weight Loss Drug Does Not Increase Cardiovascular Events

Weight Loss Drug Does Not Increase Cardiovascular Events
R&DMAG
27 Aug 2018
Share Share
UC San Diego researchers uncover root of leptin resistance

UC San Diego researchers uncover root of leptin resistance
Brittany Meiling ENDPTS
24 Aug 2018
Share Share